Schistosoma Mansoni: the Identification of Some Highly Immunogenic Surface Antigens of the Lung Stage Larvae as Promising Vaccine Candidates Against Schistosomiasis

2011 ◽  
Vol 31 (2) ◽  
pp. 157-166
Author(s):  
Samir Mahgoub
Science ◽  
1985 ◽  
Vol 227 (4686) ◽  
pp. 535-538 ◽  
Author(s):  
M. Smith ◽  
J. Clegg

1984 ◽  
Vol 3 (1) ◽  
pp. 213-219 ◽  
Author(s):  
M. Knight ◽  
A.J. Simpson ◽  
G. Payares ◽  
M. Chaudri ◽  
S.R. Smithers

1985 ◽  
Vol 16 (3) ◽  
pp. 277-288 ◽  
Author(s):  
Colette Dissous ◽  
Jean-Marie Grzych ◽  
André Capron

1979 ◽  
Vol 65 (4) ◽  
pp. 497 ◽  
Author(s):  
Eugene G. Hayunga ◽  
K. Darwin Murrell ◽  
David W. Taylor ◽  
Wilton E. Vannier

1999 ◽  
Vol 67 (10) ◽  
pp. 5508-5513 ◽  
Author(s):  
Ting-Huai Wu ◽  
Xin-Xing Gu

ABSTRACT Nontypeable Haemophilus influenzae (NTHi) is a common cause of otitis media and respiratory tract infections. Outer membrane proteins (OMP) and lipooligosaccharide (LOS) are major surface antigens of NTHi and potential vaccine candidates. De-O-acylated LOS (dLOS) or oligosaccharide (OS) was coupled to total OMP to form dLOS-OMP and OS-OMP conjugates, while a dLOS-tetanus toxoid (TT) was synthesized for comparison. These conjugates were evaluated in mice and rabbits for immunogenicity. dLOS-OMP elicited a better boostable antibody response against LOS than did dLOS-TT, while OS-OMP was not immunogenic. Formulation of the conjugates with Ribi adjuvant significantly enhanced the immunogenicity of dLOS-OMP and dLOS-TT but not that of OS-OMP. In addition, rabbit antisera elicited by dLOS-OMP but not dLOS-TT (or OMP alone) demonstrated bactericidal activity against 40% of the NTHi strains tested. These results indicate that dLOS is a better derivative of LOS than OS and that OMP is a good carrier for NTHi LOS-based conjugate vaccines.


Parasitology ◽  
1996 ◽  
Vol 112 (1) ◽  
pp. 47-58 ◽  
Author(s):  
P. G. Fallon ◽  
R. E. Fookes ◽  
G. A. Wharton

SUMMARYA temporal study of the effects on the tegument of Schistosoma mansoni adult worm following in vivo praziquantel and oxamniquine treatment was performed. Drug-induced damage to the tegument, exposure of surface antigens and attachment of host antibody occurred rapidly, within 1 h, following praziquantel treatment. Oxamniquine-treated worms required 4–8 days for these effects to be apparent. The 2 drugs differed in the degree and sites of damage on the worm surface. The administration of 2 different polyspecific rabbit sera with drug significantly increased the efficacy of praziquantel when administered with the drug, but not when given 6–9 days after drug treatment. In contrast, only 1 serum was synergistic with oxamniquine when administered with drug and both sera were synergistic when given 6–9 days after drug treatment. The effect of immune killing of drug-treated worms is discussed.


Sign in / Sign up

Export Citation Format

Share Document